Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS G12D Inhibitor, in Colorectal Cancer Treatment
Anticancer Research · 2023-10 · 43 (10) · 4341-4348
DOI: 10.21873/anticanres.16629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.09.2023. Verfasst von Masahiro Kataoka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School o…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Colorectal Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
- Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan kita118@shinshu-u.ac.jp.
Zitieren
APA
Kataoka, M., Kitazawa, M., Nakamura, S., Koyama, M., Yamamoto, Y., Miyazaki, S., Hondo, N., Tanaka, H., & Soejima, Y. (2023). Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS G12D Inhibitor, in Colorectal Cancer Treatment. Anticancer Research, 43(10), 4341-4348. https://doi.org/10.21873/anticanres.16629
Vancouver
Kataoka M, Kitazawa M, Nakamura S, Koyama M, Yamamoto Y, Miyazaki S, et al. Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS G12D Inhibitor, in Colorectal Cancer Treatment. Anticancer Research. 2023;43(10):4341-4348. doi:10.21873/anticanres.16629
BibTeX
@article{Kataoka2023,
author = {Kataoka, Masahiro and Kitazawa, Masato and Nakamura, Satoshi and Koyama, Makoto and Yamamoto, Yuta and Miyazaki, Satoru and Hondo, Nao and Tanaka, Hirokazu and Soejima, Yuji},
title = {Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS G12D Inhibitor, in Colorectal Cancer Treatment},
journal = {Anticancer Research},
year = {2023},
volume = {43},
number = {10},
pages = {4341--4348},
doi = {10.21873/anticanres.16629}
}
EUVIMED